Dr. Jeffrey W Gilman
Dr. Jeffrey W. Gilman received his B. A. in chemistry from Ithaca College in 1980, and his Ph.D. in organic chemistry from the University of California, Irvine in 1985. He is an experienced Research Chemist with a demonstrated history of working in the materials industry, skilled in Fluorescence imaging, nano-composites, nano-cellulose, interface measurements, flame retardants and Materials Science.
Founder & President
Douglas M. Fox
Douglas M. Fox received his B.S. in Chemical Engineering and his PhD in Chemistry at Michigan Technological University, in Houghton, MI. He spent two years at the Naval Research Laboratory and two years at the U.S. Naval Academy investigating the physical and thermal properties of room temperature ionic liquids and polymer nanocomposites. His research and teaching focus is on “green chemistry”, environmental solutions, and the use of natural materials.
Board Member
Board MemberCameron Ross
Cameron is a research translation and commercialization leader known for founding and scaling Celise Bioproducts from a collegiate startup into an international biomanufacturing firm. His work in product development, process optimization and account management has replaced over eight million pounds of single-use plastics across 15 countries, coordinating over $10M in transactions across F&B, chemical, medical, and CPG market segments until Celise's acquisition in 2025. He now serves as a Chemist in Residence at American University and as a Managing Partner at Bricolage Investment Group, helping researchers transition novel material and manufacturing technologies into commercial outcomes.
Board MemberDr. Martin Rusinowitz, MD
Dr. Rusinowitz is a Board-Certified neurologist who practiced in Rockville/Bethesda for more than 20 years. He subsequently entered public health service with the Food and Drug Administration serving for over 10 years as a Senior Medical Officer with the Controlled Substance Staff until 2019. He had been a member and Chair of the Maryland State Medical Society Physician Health Committee for more than 20 years and Medical Director of the Society’s Professional Rehabilitation Program until his retirement in 2025.